According to MarketsandMarkets™, the global compounding pharmacy market is projected to grow from USD 14.72 billion in 2025 to USD 19.41 billion by 2030, at a CAGR of 5.7%. Persistent drug shortages across major markets and stricter enforcement of USP standards are accelerating demand for high-quality, customized pharmaceutical solutions. As healthcare shifts toward personalization, how critical are compounding pharmacies in addressing unmet patient needs?
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57885999
Browse
- 480 Market Data Tables
- 60 Figures
- 350 Pages and in-depth TOC on “ Compounding Pharmacy Market – Global Forecast to 2030 ”.
What is driving the demand for compounded medications?
Increasing incidences of drug shortages in North America and Europe are compelling healthcare providers to rely on compounding pharmacies for tailored alternatives. Additionally, the growing emphasis on patient-specific therapies—particularly for pediatric, geriatric, and chronic disease populations—is strengthening the role of compounding in modern healthcare delivery.
Why do oral formulations dominate the product landscape?
Oral drugs accounted for the largest market share in 2024, owing to their versatility and widespread use across multiple therapeutic areas. Customized oral formulations—such as capsules, tablets, and suspensions—allow precise dosage adjustments, taste masking, and improved bioavailability. These advantages enhance patient adherence, particularly among populations with swallowing difficulties or requiring individualized dosing.
Which therapeutic segment is emerging as a key growth driver?
Hormone replacement therapy (HRT) is expected to register the fastest growth during the forecast period. The increasing prevalence of hormonal imbalances and age-related conditions is driving demand for personalized HRT solutions. Compounded therapies offer flexibility in hormone type, dosage, and delivery method, improving treatment efficacy and minimizing side effects. Advances in bioidentical hormones and transdermal delivery systems are further supporting this segment’s rapid expansion.
How is regulatory compliance shaping the market? Strict adherence to USP standards and regulatory oversight is enhancing the safety, quality, and reliability of compounded medications. This is strengthening trust among healthcare providers and patients, while also encouraging the adoption of advanced compounding technologies and sterile preparation systems.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=57885999
Regional Insights:
Which regions are leading and where are the growth opportunities? North America held the largest market share in 2024, driven by established healthcare infrastructure and high awareness of personalized medicine. Meanwhile, Asia Pacific is emerging as the fastest-growing region, supported by increasing healthcare access, rising disposable incomes, and growing demand for customized therapies in countries such as China, India, Japan, and Australia.
Market Insights:
Key players in the compounding pharmacy market include Baxter (US), Empower Pharmacy (US), B. Braun (Germany), Fagron (Netherlands), QuVa Pharma (US), SCA Pharma (US), Nephron Pharmaceuticals (US), Leiters Health (US), and Pharmaxo (UK). These companies are focusing on expanding sterile compounding capabilities, enhancing regulatory compliance, and investing in advanced formulation technologies to strengthen their market position.
As the demand for personalized medicine and reliable drug supply continues to grow, stakeholders must leverage opportunities in compounding innovation and regulatory compliance. To access comprehensive market insights, competitive analysis, and growth strategies, explore the full report today.
Related Reports:
Pain Management Devices Market – Global Forecast to 2029
Topical Drug Delivery Market – Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/compounding-pharmacy-market-57885999.html